NCCN 2024 Videos

2024 NCCN Prostate Cancer Guidelines: Updates in M1 CSPC Treatment - Rashid Sayyid & Zachary Klaassen

September 6, 2024

Details

2024 NCCN Guidelines: Managing Bone Health in Prostate Cancer Patients - Rashid Sayyid & Zachary Klaassen

July 26, 2024

Details

2024 NCCN Guidelines: Preventing Skeletal Events in Prostate Cancer - Rashid Sayyid & Zachary Klaassen

July 25, 2024

Details

2024 NCCN Guidelines Update: Metastatic Castration-Resistant Prostate Cancer Treatment - Rashid Sayyid & Zachary Klaassen

July 10, 2024

Details

2024 NCCN Guidelines: Simplifying the Management of Very Low-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen

June 19, 2024

Details

NCCN 2024 Prostate Cancer Guidelines Update: Relugolix Gains Prominence in Treating Metastatic Castration-Sensitive Prostate Cancer - Rashid Sayyid & Zachary Klaassen

June 15, 2024

Details

NCCN 2024 Prostate Cancer Guidelines Update: PARP Inhibitors in Focus - Rashid Sayyid & Zachary Klaassen

May 22, 2024

Details

NCCN 2024 Prostate Cancer Guideline Updates: Progressive M0 CSPC Management - Rashid Sayyid & Zachary Klaassen

April 3, 2024

Details

Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen

April 3, 2024

Details

NCCN 2024 Guidelines Endorse Novel Prostate Test for Precision Risk Stratification - Rashid Sayyid & Zachary Klaassen

April 3, 2024

Details